[¿Â¶óÀÎ] 2022 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2022-04-15±³À°ÀÏÀÚ : 2022-04-15
±³À°Àå¼Ò : ¿Â¶óÀÎ
±³À°ÁÖÁ¦ :
[¿Â¶óÀÎ] 2022 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
kspho@kams.or.kr ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
´ëÀü±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í Àü¹®ÀÇ 30,000¿ø, Àü°øÀÇ 20,000¿ø(»çÀüµî·Ï 4¿ù 5ÀϱîÁö)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-15 A 14:10~14:30 Updates of Chemotherapy&Transplantation À¯°ÇÈñ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-15 A 14:30~15:10 Genomics & target therapy in AML(Aaute Myeloid Leukemia) ÀÌÀç¿í(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-15 A 15:10~15:30 NGS(Next Generation Sequencing)MRD(Minimal Residual Disease) in AML(Acute Myeloid Leukemia) ½Å»õ¾Ï(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-15 A 15:30~16:10 Ç÷¾×¾Ï ±âºÎ»ç¾÷ È«°æÅÃ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-15 A 16:10~16:40 °íÇü¾Ï ±âºÎ»ç¾÷ ÀÌÁö¿ø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-15 A 16:40~17:10 ¼Ò¾ÆÇ÷¾×Á¾¾ç °ü·Ã Á¤Ã¥ ±èÇý¸®(¿ï»êÀÇ´ë)